Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma

Journal of Thoracic Oncology - Tập 14 - Trang 1912-1923 - 2019
Chao Zhang1,2, Jianjun Zhang3,4, Fang-Ping Xu5, Yin-Guang Wang6, Zhi Xie1, Jian Su1, Song Dong1, Qiang Nie1, Yang Shao7, Qing Zhou1, Jin-Ji Yang1, Xue-Ning Yang1, Xu-Chao Zhang1, Zhi Li5, Yi-Long Wu1, Wen-Zhao Zhong1
1Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People’s Republic of China
2School of Medicine, South China University of Technology, Guangzhou, People’s Republic of China
3Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
4Department of Genomic Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
5Department of Pathology, Guangdong Provincial Peoples’ Hospital, Guangzhou, People's Republic of China
6Nanjing Geneseeq Technology Inc., Najing, Jiangsu, People's Republic of China
7Translational Medicine Research Institute, Geneseeq Technology, Inc., Toronto, Ontario, Canada

Tài liệu tham khảo

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322/caac.21492 Wright, 2006, Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials, Thorax, 61, 597, 10.1136/thx.2005.051995 Hirsch, 2017, Lung cancer: current therapies and new targeted treatments, Lancet, 389, 299, 10.1016/S0140-6736(16)30958-8 Gettinger, 2018, Five-year follow-up of nivolumab in previously treated advanced non-small-cell lung cancer: results from the CA209-003 study, J Clin Oncol, 36, 1675, 10.1200/JCO.2017.77.0412 Hunter, 2018, Genetic insights into the morass of metastatic heterogeneity, Nat Rev Cancer, 18, 211, 10.1038/nrc.2017.126 Wang, 2018, Lung cancer heterogeneity and new strategies for drug therapy, Annu Rev Pharmacol Toxicol, 58, 531, 10.1146/annurev-pharmtox-010716-104523 Aberle, 2011, Reduced lung-cancer mortality with low-dose computed tomographic screening, N Engl J Med, 365, 395, 10.1056/NEJMoa1102873 Bongiolatti, 2018, Long-term results after surgical treatment of the dominant lung adenocarcinoma associated with ground-glass opacities, J Thorac Dis, 10, 4838, 10.21037/jtd.2018.07.21 Travis, 2013, Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, Arch Pathol Lab Med, 137, 685, 10.5858/arpa.2012-0264-RA Travis, 2011, International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma, J Thorac Oncol, 6, 244, 10.1097/JTO.0b013e318206a221 Hung, 2014, Predictive value of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival, J Clin Oncol, 32, 2357, 10.1200/JCO.2013.50.1049 Inamura, 2018, Clinicopathological characteristics and mutations driving development of early lung adenocarcinoma: tumor initiation and progression, Int J Mol Sci, 19, 10.3390/ijms19041259 Imielinski, 2012, Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing, Cell, 150, 1107, 10.1016/j.cell.2012.08.029 Swanton, 2012, Intratumor heterogeneity: evolution through space and time, Cancer Res, 72, 4875, 10.1158/0008-5472.CAN-12-2217 Zhang, 2014, Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing, Science, 346, 256, 10.1126/science.1256930 Nahar, 2018, Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing, Nat Commun, 9, 216, 10.1038/s41467-017-02584-z Li, 2010, Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, 26, 589, 10.1093/bioinformatics/btp698 McKenna, 2010, The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res, 20, 1297, 10.1101/gr.107524.110 Cibulskis, 2013, Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples, Nat Biotechnol, 31, 213, 10.1038/nbt.2514 Ramos, 2015, Oncotator: cancer variant annotation tool, Hum Mutat, 36, E2423, 10.1002/humu.22771 Talevich, 2016, CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing, PLoS Comput Biol, 12, 10.1371/journal.pcbi.1004873 Beroukhim, 2007, Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma, Proc Natl Acad Sci U S A, 104, 20007, 10.1073/pnas.0710052104 Carter, 2012, Absolute quantification of somatic DNA alterations in human cancer, Nat Biotechnol, 30, 413, 10.1038/nbt.2203 Cappuzzo, 2009, Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients, J Clin Oncol, 27, 1667, 10.1200/JCO.2008.19.1635 2014, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 511, 543, 10.1038/nature13385 Jordan, 2017, Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies, Cancer Discov, 7, 596, 10.1158/2159-8290.CD-16-1337 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 Zhang, 2019, Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients, Nat Commun, 10, 1772, 10.1038/s41467-019-09762-1 Oikawa, 2017, PRG4 expression in myxoid liposarcoma maintains tumor cell growth through suppression of an antitumor cytokine IL-24, Biochem Biophys Res Commun, 485, 209, 10.1016/j.bbrc.2017.02.055 Pan, 2018, Structural insights into ankyrin repeat-mediated recognition of the kinesin motor protein KIF21A by KANK1, a scaffold protein in focal adhesion, J Biol Chem, 293, 1944, 10.1074/jbc.M117.815779 Zhang, 2014, Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients, Tumour Biol, 35, 4419, 10.1007/s13277-013-1581-6 Matsuda, 2016, SERPINI1 regulates epithelial-mesenchymal transition in an orthotopic implantation model of colorectal cancer, Cancer Sci, 107, 619, 10.1111/cas.12909 Yan, 2016, Neural cell adhesion protein CNTN1 promotes the metastatic progression of prostate cancer, Cancer Res, 76, 1603, 10.1158/0008-5472.CAN-15-1898 Chen, 2018, Overexpression of contactin 1 promotes growth, migration and invasion in Hs578T breast cancer cells, BMC Cell Biol, 19, 5, 10.1186/s12860-018-0154-3 Roper, 2019, APOBEC mutagenesis and copy-number alterations are drivers of proteogenomic tumor evolution and heterogeneity in metastatic thoracic tumors, Cell Rep, 26, 2651, 10.1016/j.celrep.2019.02.028 Teng, 2015, Classifying cancers based on T-cell infiltration and PD-L1, Cancer Res, 75, 2139, 10.1158/0008-5472.CAN-15-0255 Jamal-Hanjani, 2017, Tracking the evolution of non-small-cell lung cancer, N Engl J Med, 376, 2109, 10.1056/NEJMoa1616288 Krysan Gerlinger, 2012, Intratumor heterogeneity and branched evolution revealed by multiregion sequencing, N Engl J Med, 366, 883, 10.1056/NEJMoa1113205 Lee, 2011, Chromosomal instability confers intrinsic multidrug resistance, Cancer Res, 71, 1858, 10.1158/0008-5472.CAN-10-3604